| Jul 17 |
Syros (SYRS) Stock Rises More Than 35% in 3 Months: Here's Why
|
| Jul 15 |
ANI Pharmaceuticals Announces the FDA Approval and Launch of L-Glutamine Oral Powder
|
| Jul 2 |
ANI Pharmaceuticals Announces the FDA Approval and Launch of Naproxen Delayed-Release Tablets, USP
|
| Jun 25 |
Alimera (ALIM) Rises on Merger Deal With ANI Pharmaceuticals
|
| Jun 25 |
ANI Pharmaceuticals’ CEO Nikhil Lalwani Named EY Entrepreneur Of The Year® 2024 New Jersey Award Winner
|
| Jun 25 |
Nasdaq Records Worst Session Since April With Nvidia Plunging 7%: Dow Jones Sees Modest Gains Amid Mixed Market Close
|
| Jun 24 |
Generics Player ANI Pharmaceuticals Strengthens Rare Disease Segment With $380M Alimera Sciences Deal
|
| Jun 24 |
Alimera Sciences shares jump by 77% after being acquired by ANI
|
| Jun 24 |
Alimera Sciences leaps on takeover deal by ANI Pharmaceuticals
|
| Jun 24 |
ANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera Sciences
|
